Azepindol
Azepindol
(IUPAC ) ime
2,3,4,5-tetrahidro-1H -[1,4]diazepino[1,2-a]indol
Klinički podaci
Identifikatori
CAS broj
26304-61-0
ATC kod
nije dodeljen
PubChem [ 1] [ 2]
33471
ChemSpider [ 3]
30893
UNII
6BB6FW9T8J Y
KEGG [ 4]
D03035 Y
ChEMBL [ 5]
CHEMBL10758 Y
Hemijski podaci
Formula
C 12 H 14 N 2
Mol. masa
186,25 g/mol
SMILES
eMolekuli & PubHem
InChI
InChI=1S/C12H14N2/c1-2-5-12-10(4-1)8-11-9-13-6-3-7-14(11)12/h1-2,4-5,8,13H,3,6-7,9H2 Y Key: FEJCIXJKPISCJV-UHFFFAOYSA-N Y
Farmakoinformacioni podaci
Trudnoća
?
Pravni status
Azepindol (McN-2453 ) je triciklično jedinjenje sa antidepresivnim i antihipertenzivnim dejstvom. On je razvijen tokom kasnih 1960-tih , ali nije plasiran na tržište.[ 6]
Povezano
Reference
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.” . Drug Discov Today 15 (23-24): 1052-7. DOI :10.1016/j.drudis.2010.10.003 . PMID 20970519 . edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4 : 217-241. DOI :10.1016/S1574-1400(08)00012-1 .
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining” . J Cheminform 2 (1): 3. DOI :10.1186/1758-2946-2-3 . PMID 20331846 . edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG” . Yeast 17 (1): 48–55. DOI :10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H .
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI :10.1093/nar/gkr777 . PMID 21948594 . edit
↑ Dictionary of pharmacological agents .
Spoljašnje veze
Portal Medicina
Portal Hemija
Inhibitori preuzimanja serotonin-norepinefrina (SNRI)
Inhibitori preuzimanja serotonin-norepinefrin-dopamina (SNDRI)
Inhibitori preuzimanja norepinefrin-dopamina (NDRI)
Agensi oslobađanja norepinefrin-dopamina (NDRA)
Agensi oslobađanja serotonin-norepinefrin-dopamina (SNDRA)
Selektivni pojačivači preuzimanja serotonina (SSRE)
Drugi
Serotoninski antagonisti i inhibitori preuzimanja (SARI)
Noradrenergički i specifični serotonergički antidepresanti (NaSSA)
Norepinefrin-dopamin disinhibitori (NDDI)
Serotoninski modulatori i stimulatori (SMS)
Neselektivni
MAOA -Selektivni
MAOB -Selektivni
dsrd (o,d,b,p,a,s), spes, spvo
proc, lek(N5A/5B/5C /6A /6B/6D)
The article is a derivative under the Creative Commons Attribution-ShareAlike License .
A link to the original article can be found here and attribution parties here
By using this site, you agree to the Terms of Use . Gpedia ® is a registered trademark of the Cyberajah Pty Ltd